Search

Full data chronic kidney disease trial efficacy

Positive full data results announced from the EMPA-KIDNEY Phase III trial in adults with chronic kidney disease

We’re All In

Watch our video to learn about our approach to innovation and partnerships

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.

Co-creation with Communities

Making More Health has launched co-creation projects in Asia, Africa, Europe and other localities around the world with top social entrepreneurs.

Congress Patient Benefit

The participation in scientific congresses is firmly established in the event agenda of any pharmaceutical company. But what is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical represent

Immunology

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in immunology.

CHMP recommends conditional approval for first GPP treatment

CHMP recommends conditional marketing authorization for novel IL-36 receptor monoclonal antibody, spesolimab, as first treatment for generalized pustular psoriasis flares

New treatment for chronic kidney disease approved in the EU

The European Commission (EC) has approved Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease

Malta

Embracing diversity in clinical trials

At Boehringer Ingelheim, we understand the crucial need of embracing diversity in clinical trials as an opportunity to enable more equitable healthcare.

Thailand

New spesolimab data show significant improvement in GPP flares

preserved-heart-failure-treatment-approval-europe

Pakistan

Tips to help you start your patient advocacy journey

Advocating for yourself as a patient can be daunting. Jeff Dunn, President of Union for International Cancer Control (UICC), shares some tips

Social Media Data Privacy and Cookies Statement

Smart Factory: Digitalizing production facilities

How our digitalized production facilities help our colleagues and patients

SPEVIGO CHMP positive opinion new indications

CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®

garbage game